# Adlai Nortye

**Canonical:** https://apis.io/providers/adlai-nortye/  
**Website:** https://www.adlainortye.com/  
**APIs profiled:** 0

Adlai Nortye is a global clinical-stage biopharmaceutical company, headquartered in Hangzhou, China with US operations in New Jersey, developing differentiated immuno-oncology and precision-targeted cancer medicines. Its pipeline covers two therapeutic areas: precision RAS pathway targeted therapies — the oral pan-RAS(ON) inhibitor AN9025 and the CEACAM5-targeting antibody-drug conjugate AN4035 built on the company's proprietary RASiCA (RAS Inhibitor Conjugated Antibody) platform — and next-generation PD-1/L1 pathway modulating immunotherapies including AN8025, a multi-functional T-cell and antigen-presenting-cell modulating fusion protein, plus the oral EP4 antagonist AN0025 (palupiprant). The company is listed on Nasdaq under the ticker ANL. Adlai Nortye publishes no developer program, API, SDK or machine-readable contract of any kind.

## Kin Score — 10.7 / 100 (minimal)

Scored 2026-09-07 under rubric 0.20.0.

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 4.8 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Adlai Nortye Domain Security** — TLSv1.2 · HSTS

## Tags

Company, Biotechnology, Pharmaceuticals, Life Sciences, Healthcare, Oncology, Clinical Trials, Drug Development

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/adlai-nortye/). Scores are computed from the provider's own public artifacts under a published rubric.